SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 105.64+0.1%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Hutton who wrote (533)12/10/1997 7:44:00 PM
From: Cytokine1  Read Replies (3) of 3202
 
Projected 1998 earnings $.75 gives a PPE of 47.....

My guess (and just a guess) as to price action is that some mutual funds took some profits. It has been a weak performer lately. I have seen no recent news to explain the weakness. Earlier this year there was a 40% correction from an intermediate top before the stock turned around and more than doubled off its low point in the correction.

I own INCY and have bought at split-adjusted prices of anywhere from $22 to $33. I am holding and hoping the price holds, too. Buying opportunity? Your decision.

INCY is the leader in bioinformatics with an impressive list of customers with signed contracts.

Now if you could convince me to buy some ANLT (it's on my watch list). { ; >

Good luck, Martin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext